<DOC>
	<DOCNO>NCT01945528</DOCNO>
	<brief_summary>Background Tendinopathy difficult problem manage result significant patient morbidity . Currently , clinical use PRP painful tendon widespread efficacy remain controversial . Current experimental research postulate different efficiency among PRP formulations.Recent review show clinical study tendinopathies perform L-PRP . The investigator aim examine efficacy pure-PRP management epicondylitis . The investigator hypothesize pure PRP associate needle intervention enhance tendon heal epicondylitis , improve function reduce pain . Methods design Randomized double blind control trial , total 80 patient randomly allocate one two group : PRP control . Interventions : PRP group , ultrasound ( US ) guide needle associate delivery multiple PRP depot alternate week total two intervention . Control Group : US-guided needling lidocaine alternate week total two intervention . Main outcome measure : Changes pain activity level , assess Disabilities Arm , Shoulder Hand ( DASH ) outcome measure score , six month intervention.The primary end-point 25 % reduction DASH . The investigator compare percentage patient , group , achieve successful treatment define reduction least 25 % DASH score . Secondary outcome measure : Changes pain function assess DASH change pain assessed visual analogue scale ( VAS ) 3 , 6 12 month follow-up . Changes sonographic feature neovascularity 3 , 6 12 month .</brief_summary>
	<brief_title>Platelet Rich Plasma ( PRP ) Chronic Epicondylitis</brief_title>
	<detailed_description />
	<mesh_term>Tennis Elbow</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<criteria>Inclusion criterion Tendinopathy present either lateral medial elbow Pain palpation lateral medial epicondyle elbow Baseline elbow pain &gt; 3/10 resisted wrist extension History least two period elbow pain lasting 10 day Symptoms last least 3 month long Body Mass Index 20 35 . Commitment comply study procedures The patient must give write informed consent Presence full tendon tear Body mass index &gt; 35 Systemic autoimmune rheumatologic disease ( connective tissue disease systemic necrotizing vasculitis ) Poorly control diabetes mellitus ( glycosylated hemoglobin 9 % ) Blood disorder ( thrombopathy , thrombocytopenia , anemia Hb &lt; 9 ) Patients receive immunosuppressive treatment Received local steroid injection within 3 month randomization receive nonsteroidal antiinflammatory , opioids oral corticosteroid within 15 day inclusion study Severe heart diseasePatients unable comply schedule visit , work spend long period away habitual residence . Patients active cancer cancer diagnose last five year . Analytical Diagnosis Hepatitis B , C HIV infection . Pregnant lactating . People take drug clinical investigation participate investigational study clinic ( authorize ) within 30 day prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Platelet Rich Plasma</keyword>
	<keyword>tendinopathy</keyword>
	<keyword>epicondylitis</keyword>
	<keyword>ultrasound</keyword>
	<keyword>injection therapy</keyword>
	<keyword>needle tenotomy</keyword>
</DOC>